Title |
Complement component 5a (C5a)
|
---|---|
Published in |
International Journal of Biochemistry & Cell Biology, April 2009
|
DOI | 10.1016/j.biocel.2009.04.005 |
Pubmed ID | |
Authors |
Helga D. Manthey, Trent M. Woodruff, Stephen M. Taylor, Peter N. Monk |
Abstract |
The 74 amino acid glycoprotein, complement component 5a (C5a), is a potent pro-inflammatory mediator cleaved enzymatically from its precursor, C5, upon activation of the complement cascade. C5a is quickly metabolised by carboxypeptidases, forming the less potent C5adesArg. Acting via a classical G protein-coupled receptor, CD88, C5a and C5adesArg exert a number of effects essential to the innate immune response, while their actions at the more recently discovered non-G protein-coupled receptor, C5L2 (or GPR77), remain unclear. The widespread expression of C5a receptors throughout the body allows C5a to elicit a broad range of effects. Thus, C5a has been found to be a significant pathogenic driver in a number of immuno-inflammatory diseases, making C5a inhibition an attractive therapeutic strategy. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Germany | 1 | <1% |
Unknown | 151 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 25 | 16% |
Student > Bachelor | 25 | 16% |
Student > Ph. D. Student | 23 | 15% |
Student > Master | 17 | 11% |
Student > Doctoral Student | 11 | 7% |
Other | 22 | 14% |
Unknown | 30 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 33 | 22% |
Medicine and Dentistry | 29 | 19% |
Biochemistry, Genetics and Molecular Biology | 25 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 8% |
Immunology and Microbiology | 7 | 5% |
Other | 14 | 9% |
Unknown | 33 | 22% |